Moderna And Pfizer Have Published Detailed Information About Their Vaccine Trials
Several pharmaceutical companies have published detailed information about the third stage of testing their COVID-19 vaccines, including how they are going to ensure the safety and effectiveness of these vaccines. On Thursday, such data was published by Moderna and Pfizer. AstraZeneca also announced its intention to publish such data.
According to the New York Times, pharmaceutical companies have abandoned the traditional secrecy in the development of vaccines and medicines due to pressure from the scientific community and the public at large. Among other things, the public is concerned about whether the US President is trying to speed up the creation of a vaccine so that it is approved before the US presidential election. Also, scientists are calling for the publication of data on vaccine trials so that external experts can also evaluate them and, if necessary, identify omissions and shortcomings.
Now pharmaceutical companies have published detailed data on how test participants are selected, how their condition is monitored, how they are protected from COVID-19 infection, the test schedule, and so on. Usually, such data is published after the end of the tests. Thirty thousand volunteers take part in Moderna trials, in the case of Pfizer — 44 thousand.
The world's first coronavirus vaccine was registered in Russia in early August. The Ministry of Health reported that four more vaccines are being prepared for registration.